KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 122 filers reported holding KYMERA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,090,945 | -37.6% | 366,255 | +3.2% | 0.00% | -50.0% |
| Q2 2023 | $8,159,795 | -18.2% | 354,928 | +5.4% | 0.00% | 0.0% |
| Q1 2023 | $9,980,184 | +17.1% | 336,827 | -1.4% | 0.00% | 0.0% |
| Q4 2022 | $8,522,367 | +18.0% | 341,441 | +2.9% | 0.00% | 0.0% |
| Q3 2022 | $7,221,000 | +10.0% | 331,738 | -0.5% | 0.00% | +100.0% |
| Q2 2022 | $6,564,000 | -51.5% | 333,378 | +4.2% | 0.00% | -50.0% |
| Q1 2022 | $13,536,000 | -37.1% | 319,870 | -5.6% | 0.00% | -50.0% |
| Q4 2021 | $21,516,000 | +8.1% | 338,900 | +0.1% | 0.00% | 0.0% |
| Q3 2021 | $19,897,000 | +58.1% | 338,723 | +30.5% | 0.00% | +100.0% |
| Q2 2021 | $12,587,000 | +175.7% | 259,515 | +120.9% | 0.00% | +100.0% |
| Q1 2021 | $4,566,000 | -39.6% | 117,501 | -3.6% | 0.00% | 0.0% |
| Q4 2020 | $7,559,000 | – | 121,926 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,858,262 | $81,429,842 | 12.61% |
| Aquilo Capital Management, LLC | 782,219 | $10,872,844 | 9.85% |
| BVF INC/IL | 4,739,004 | $65,872,156 | 1.78% |
| Redmile Group, LLC | 1,868,507 | $25,972,247 | 1.24% |
| Artal Group S.A. | 1,805,346 | $25,094 | 1.08% |
| Deer Management Co. LLC | 615,895 | $8,560,941 | 1.04% |
| Avoro Capital Advisors LLC | 3,855,000 | $53,584,500 | 0.84% |
| Rock Springs Capital Management LP | 1,504,351 | $20,910,479 | 0.56% |
| AtonRa Partners | 19,172 | $266,491 | 0.56% |
| Baker Brothers Advisors | 4,750,400 | $66,030,560 | 0.38% |